QR-koodi

Infantile BCG osteomyelitis ultimately diagnosed as a result of trauma

The BCG vaccine is effective in preventing severe tuberculosis infections in infants and young children, and it is commonly administered in Japan to those aged between 5 to 8 months. Although the incidence of adverse reactions is low, disseminated lymphadenitis and osteomyelitis have been reported a...

Täydet tiedot

Tallennettuna:
Päätekijät: Katsuhiko Tabata, MD, Osamu Miyazaki, MD, Ayako Imai, MD, Reiko Okamoto, MD, Mikiko Miyasaka, MD, Yoshiyuki Tsutsumi, MD, Yoko Anami, MD, Atsuhito Seki, MD, Tatsuki Ikuse, MD, PhD, Toshinao Kawai, MD, PhD, Takashi Ishikawa, MD, PhD, Chizuko Haga, MD, Takako Yoshioka, MD, Shunsuke Nosaka, MD
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2025-03-01
Sarja:Radiology Case Reports
Aiheet:
BCG osteomyelitis
BCG vaccine
Pediatrics
Adverse reactions
Linkit:http://www.sciencedirect.com/science/article/pii/S1930043324013967
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia